ALK and ROS1 kinases demonstrate significant similarities with regard to amino acid sequence, mode of genetic alterations, the spectrum of associated tumor types, correlations with clinical characteristics of cancer disease, and patterns of sensitivity to tyrosine kinase inhibitors. The gene discussed is ROS1; the disease is cancer.